"Peanut Hypersensitivity" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Allergic reaction to peanuts that is triggered by the immune system.
| Descriptor ID |
D021183
|
| MeSH Number(s) |
C20.543.480.370.572.750
|
| Concept/Terms |
Peanut Hypersensitivity- Peanut Hypersensitivity
- Groundnut Hypersensitivity
- Hypersensitivity, Groundnut
- Allergy, Peanut
- Allergies, Peanut
- Peanut Allergies
- Hypersensitivity, Peanut
- Peanut Allergy
|
Below are MeSH descriptors whose meaning is more general than "Peanut Hypersensitivity".
Below are MeSH descriptors whose meaning is more specific than "Peanut Hypersensitivity".
This graph shows the total number of publications written about "Peanut Hypersensitivity" by people in this website by year, and whether "Peanut Hypersensitivity" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2014 | 2 | 0 | 2 |
| 2015 | 2 | 0 | 2 |
| 2016 | 1 | 0 | 1 |
| 2017 | 3 | 0 | 3 |
| 2018 | 3 | 1 | 4 |
| 2019 | 8 | 0 | 8 |
| 2020 | 6 | 0 | 6 |
| 2021 | 4 | 1 | 5 |
| 2022 | 7 | 0 | 7 |
| 2023 | 5 | 0 | 5 |
| 2024 | 3 | 0 | 3 |
| 2025 | 4 | 1 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Peanut Hypersensitivity" by people in Profiles.
-
Epicutaneous immunotherapy: A review of safety and efficacy. Pediatr Allergy Immunol. 2025 Apr; 36(4):e70096.
-
Accuracy of bead-based epitope assay testing for peanut allergy diagnosis: Real-world pediatric population study. Ann Allergy Asthma Immunol. 2025 Aug; 135(2):197-202.e1.
-
Long-Term Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: An Open-Label Active Treatment (REALISE Study). J Allergy Clin Immunol Pract. 2025 May; 13(5):1190-1200.e3.
-
Efficacy and Safety of Epicutaneous Immunotherapy in Peanut-Allergic Toddlers: Open-Label Extension to EPITOPE. J Allergy Clin Immunol Pract. 2025 May; 13(5):1176-1187.e7.
-
Infant and Toddler Peanut Oral Immunotherapy: Initiation Before Age 2 Increases Ad Libitum Peanut Consumption. J Allergy Clin Immunol Pract. 2025 Apr; 13(4):885-892.
-
Real-world adoption of peanut oral immunotherapy in infants and toddlers. J Allergy Clin Immunol Pract. 2024 Aug; 12(8):2196-2198.e1.
-
Evaluation and Modification of a Shared Decision-Making Tool for Peanut Allergy Management. Curr Allergy Asthma Rep. 2024 Jun; 24(6):303-315.
-
Real-world safety experience with Peanut (Arachis hypogaea) Allergen Powder-dnfp in 2500 children with peanut allergy. Ann Allergy Asthma Immunol. 2024 06; 132(6):778-780.
-
Reaching Communities Through Food Allergy Advocacy, Research, and Education: A Comprehensive Analysis. J Allergy Clin Immunol Pract. 2024 02; 12(2):310-315.
-
Combining avidin with CD63 improves basophil activation test accuracy in classifying peanut allergy. Allergy. 2024 02; 79(2):445-455.